These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2503439)

  • 1. Production of H-2 class II (Ia.7) antibody is under Ir gene control.
    Hauptfeld-Dolejsek V; Shreffler DC
    Immunogenetics; 1989; 30(2):126-7. PubMed ID: 2503439
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic control of the immune response to myoglobins. IV. Inhibition of determinant-specific Ir gene-controlled antigen presentation and induction of suppression by pretreatment of presenting cells with anti-Ia antibodies.
    Berzofsky JA; Richman LK
    J Immunol; 1981 May; 126(5):1898-904. PubMed ID: 6163822
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies to mouse MHC antigens. I. Serologic characterization of ten anti-H-2 and anti-Ia reagents.
    Hauptfeld V; Nahm M; Hauptfeld M; Shreffler DC
    Immunogenetics; 1984; 19(2):169-73. PubMed ID: 6583159
    [No Abstract]   [Full Text] [Related]  

  • 4. Responses of B6.C-H-2bm12 to heterologous insulins show no correlation with the putative gene conversion but define Iabm12 as functionally unique.
    Hansen TH; Walsh WD; Rubocki RJ; Kapp JA
    J Mol Cell Immunol; 1986; 2(6):359-68. PubMed ID: 3151061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response gene function correlates with the expression of an Ia antigen. II. A quantitative deficiency in Ae:E alpha complex expression causes a corresponding defect in antigen-presenting cell function.
    Matis LA; Jones PP; Murphy DB; Hedrick SM; Lerner EA; Janeway CA; McNicholas JM; Schwartz RH
    J Exp Med; 1982 Feb; 155(2):508-23. PubMed ID: 6173457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the T cell self-specificity repertoire by treatment with anti-Ia antibody during embryonic life.
    Kimoto M; Kishimoto S
    Eur J Immunol; 1986 Jul; 16(7):835-9. PubMed ID: 2941310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.
    Germain RN; Bhattacharya A; Dorf ME; Springer TA
    J Immunol; 1982 Mar; 128(3):1409-13. PubMed ID: 6173436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid (combinatorial) Ia antigens mediate histoincompatibility, auto and alloreactivity, and immune recognition.
    Lafuse WP; David CS
    Transplant Proc; 1981 Dec; 13(4):1846-9. PubMed ID: 6800081
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alteration of murine Ir-Thy-1 gene product on anti-Thy-1 response.
    Quackenbush LJ; Gorzynski TJ; Dowjat WK; Zaleski MB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):880-2. PubMed ID: 2908555
    [No Abstract]   [Full Text] [Related]  

  • 11. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes.
    Roopenian DC; Davis AP
    Immunogenetics; 1989; 30(5):335-43. PubMed ID: 2530167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic properties of 36 new H-2 congenic strains and 4 independently derived strains, W10LT, DDD, BZH, and FM.
    Hauptfeld-Dolejsek V; Shreffler DC
    Immunogenetics; 1989; 30(2):132-6. PubMed ID: 2759664
    [No Abstract]   [Full Text] [Related]  

  • 13. IA mutation affects anti-Thy-1 response in mice.
    Quackenbush LJ; Dowjat WK; Zaleski MB
    Immunogenetics; 1985; 21(6):617-21. PubMed ID: 3924823
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of autoimmune diseases with antibody to immune response gene products or to T-cell surface markers.
    Steinman L; Waldor MK; Zamvil SS; Lim M; Herzenberg L; Herzenberg L; McDevitt HO; Mitchell D; Sriram S
    Ann N Y Acad Sci; 1986; 475():274-84. PubMed ID: 3098154
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of experimental autoimmune thyroiditis in mice by anti-I-A antibodies.
    Vladutiu AO; Steinman L
    Cell Immunol; 1987 Oct; 109(1):169-80. PubMed ID: 3498540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serologic and cellular methods for the definition of Ia specificities.
    Pla M; Birnbaum D; Guimezanes A; Colombani M; Colombani J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1051-4. PubMed ID: 6168063
    [No Abstract]   [Full Text] [Related]  

  • 17. Interspecies cross-reactivity of Class II antigen of MHC determined by syngeneic, allogeneic and xenogeneic B and T cells.
    Yano A; Yabu K; Yui K; Yamashita K; Aosai F
    Immunobiology; 1984 Dec; 168(3-5):154-66. PubMed ID: 6335702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies.
    Sriram S; Topham DJ; Carroll L
    J Immunol; 1987 Sep; 139(5):1485-9. PubMed ID: 3497972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many class II immune response genes? A reappraisal of the evidence.
    Simpson E; Lieberman R; Andó I; Sachs DH; Paul WE; Berzofsky JA
    Immunogenetics; 1986; 23(5):302-8. PubMed ID: 3086223
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of the IA hybrid molecule affecting anti-Thy-1 responsiveness.
    Quackenbush LJ; Dowjat WK; Gorzynski TJ; Zaleski MB
    Transplantation; 1987 Jun; 43(6):925-8. PubMed ID: 2884762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.